CD123 is the α-subunit of the interleukin-3 receptor; it represents a potential therapeutic target in systemic mastocytosis (SM) given its absent expression on normal/reactive mast cells (MCs) and ...
Currently, the most powerful independent prognostic factor for progression-free survival (PFS) among ISM patients relies on the presence of multilineage involvement of myeloid or myeloid plus lymphoid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results